Mert Aktar
CIK: 0002040256
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KYTX
Kyverna Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Aktar Mert
Aktar Mert (SEC CIK 0002040256) files insider reports with the SEC as Director of Kyverna Therapeutics, Inc. (KYTX).
Signal8 holds 4 ownership filings by Aktar Mert (1 Form 3, 3 Form 4), filed between Oct 24, 2024 and May 29, 2026. Those filings report 3 transactions, from Oct 21, 2024 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Aktar Mert's filings is in EMERYVILLE, CA.
Recent filings by Aktar Mert
Other insiders filing for Kyverna Therapeutics, Inc. (KYTX)
- CLARK IAN T, Director
- Cohen Fred E, Director
- SEIDENBERG BETH C, Director
- Shaw Christi, Executive Chairperson
- Martini Gregory S., Chief Financial Officer
- Dac Nadia, Chief Commercial Officer